Alzheimer’s Can Follow HIV And Become Chronic Condition If Science Advances, Woodcock Argues

The acting US FDA commissioner equates drug development in the neurodegenerative diseases to work on HIV.

Janet Woodcock at Senate Appropriations Subcommittee hearing.
Acting FDA Commissioner Janet Woodcock answers questions during a Senate appropriations subcommittee hearing. • Source: Screenshot

More from US FDA

More from Agency Leadership